Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2.

Glaser L, Kuhl M, Stegmuller J, Rückert C, Myronovskyi M, Kalinowski J, Luzhetskyy A, Wittmann C (2021)
Microbial cell factories 20(1): 111 .

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Glaser, Lars; Kuhl, Martin; Stegmuller, Julian; Rückert, ChristianUniBi ; Myronovskyi, Maksym; Kalinowski, JörnUniBi; Luzhetskyy, Andriy; Wittmann, Christoph
Abstract / Bemerkung
BACKGROUND: Pamamycins are macrodiolides of polyketide origin which form a family of differently large homologues with molecular weights between 579 and 663. They offer promising biological activity against pathogenic fungi and gram-positive bacteria. Admittedly, production titers are very low, and pamamycins are typically formed as crude mixture of mainly smaller derivatives, leaving larger derivatives rather unexplored so far. Therefore, strategies that enable a more efficient production of pamamycins and provide increased fractions of the rare large derivatives are highly desired. Here we took a systems biology approach, integrating transcription profiling by RNA sequencing and intracellular metabolite analysis, to enhance pamamycin production in the heterologous host S. albus J1074/R2.; RESULTS: Supplemented with L-valine, the recombinant producerS. albus J1074/R2 achieved a threefold increased pamamycin titer of 3.5mg L-1 and elevated fractions of larger derivatives: Pam 649 was strongly increased, and Pam 663 was newly formed. These beneficial effects were driven by increased availability of intracellular CoA thioesters, the building blocks for the polyketide, resulting from L-valine catabolism. Unfavorably, L-valine impaired growth of the strain, repressed genes of mannitol uptake and glycolysis, and suppressed pamamycin formation, despite the biosynthetic gene cluster was transcriptionallyactivated, restricting production to the post L-valine phase. A deletion mutant of the transcriptional regulator bkdR, controlling a branched-chain amino acid dehydrogenase complex, revealed decoupled pamamycin biosynthesis. The regulator mutant accumulated the polyketide independent of the nutrient status. Supplemented with L-valine, the novel strain enabled the biosynthesis of pamamycin mixtures with up to 55% of the heavy derivatives Pam 635, Pam 649, and Pam 663:almost 20-fold more than the wild type.; CONCLUSIONS: Our findings open the door to provide rare heavy pamamycins at markedly increased efficiency and facilitate studies to assess their specific biological activities and explore this important polyketide further.
Erscheinungsjahr
2021
Zeitschriftentitel
Microbial cell factories
Band
20
Ausgabe
1
Art.-Nr.
111
eISSN
1475-2859
Page URI
https://pub.uni-bielefeld.de/record/2955521

Zitieren

Glaser L, Kuhl M, Stegmuller J, et al. Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2. Microbial cell factories. 2021;20(1): 111 .
Glaser, L., Kuhl, M., Stegmuller, J., Rückert, C., Myronovskyi, M., Kalinowski, J., Luzhetskyy, A., et al. (2021). Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2. Microbial cell factories, 20(1), 111 . https://doi.org/10.1186/s12934-021-01602-6
Glaser, L., Kuhl, M., Stegmuller, J., Rückert, C., Myronovskyi, M., Kalinowski, J., Luzhetskyy, A., and Wittmann, C. (2021). Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2. Microbial cell factories 20:111 .
Glaser, L., et al., 2021. Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2. Microbial cell factories, 20(1): 111 .
L. Glaser, et al., “Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2.”, Microbial cell factories, vol. 20, 2021, : 111 .
Glaser, L., Kuhl, M., Stegmuller, J., Rückert, C., Myronovskyi, M., Kalinowski, J., Luzhetskyy, A., Wittmann, C.: Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2. Microbial cell factories. 20, : 111 (2021).
Glaser, Lars, Kuhl, Martin, Stegmuller, Julian, Rückert, Christian, Myronovskyi, Maksym, Kalinowski, Jörn, Luzhetskyy, Andriy, and Wittmann, Christoph. “Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2.”. Microbial cell factories 20.1 (2021): 111 .

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 34082758
PubMed | Europe PMC

Suchen in

Google Scholar